Patient Navigator Plus Remote Mobile Health Adherence Support with Incentives to Improve Linkage and Retention Among Hospitalized Patients with Opioid and Methamphetamine Use Who Initiate Buprenorphine (Aim 2), Washington, 2019-2021 (ICPSR 39818)
Version Date: Apr 16, 2026 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Judith I. Tsui, University of Washington
https://doi.org/10.3886/ICPSR39818.v1
Version V1
Summary View help for Summary
This data is part of a retrospective, observational study of patients hospitalized in Washington State and initiated on buprenorphine or Methadone from 05-2019 to 12-2021. Researchers aimed to examine 1) healthcare utilization outcomes (ED visits and hospital readmission) at 30-, 90- and 180-days post-discharge and 2) the associations between baseline MA use and healthcare utilization.
Citation View help for Citation
Export Citation:
Funding View help for Funding
Subject Terms View help for Subject Terms
Geographic Coverage View help for Geographic Coverage
Smallest Geographic Unit View help for Smallest Geographic Unit
State
Restrictions View help for Restrictions
Users are reminded that these data are to be used solely for statistical analysis and reporting of aggregated information, and not for the investigation of specific individuals or organizations.
Access to the data is restricted. Users interested in obtaining these data must complete a Restricted Data Use Agreement. Data are provided via ICPSR's Virtual Data Enclave (VDE). Apply for access to these data through the ICPSR VDE portal. Information and instructions are available within the data portal. For further assistance please reference the VDE Guide to learn about the application process, about using the VDE, and how to request disclosure review of VDE output.
Distributor(s) View help for Distributor(s)
Time Period(s) View help for Time Period(s)
Date of Collection View help for Date of Collection
Data Collection Notes View help for Data Collection Notes
-
This release is a Fast Track Release. Users should consult the investigator(s) if further information is needed.
Time Method View help for Time Method
Universe View help for Universe
Patients were included in the study sample if they were 18 to 64 years old at the time of being hospitalized. Patients were initiated on methadone or buprenorphine by the addiction medicine consult service between May 2019 and December 2021, were insured by Washington State Medicaid at the time of the hospitalization, and provided self-report information about their past 30-day methamphetamine use in structured interviews completed around the time of MOUD initiation.
Data Type(s) View help for Data Type(s)
Mode of Data Collection View help for Mode of Data Collection
Presence of Common Scales View help for Presence of Common Scales
Government Performance and Results Act (GPRA) Client Outcome Measures for Discretionary Program interviews, typically completed within about 4 days of initiation of medications for opioid use disorder.
HideNotes
The public-use data files in this collection are available for access by the general public. Access does not require affiliation with an ICPSR member institution.
ICPSR usually offers files in multiple formats for researchers to be able to access data and documentation in formats that work well within their needs. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR’s Accessibility Center.
One or more files in this data collection have special restrictions. Restricted data files are not available for direct download from the website; click on the Restricted Data button to learn more.
This study is maintained and distributed by the National Addiction and Health Data Archive Program (NAHDAP). NAHDAP is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).